National Launch of IscAlert™

Sensocure welcomes you to the National launch of IscAlert™ at Clarion Hotel The Hub, Oslo, February 5, 2026.

Sensocure is an ambitious Norwegian medical technology company, established in 2011. Our first target is to commercialise IscAlert™, the world's first implantable micro sensor monitoring local tissue pCO₂ which provides the ability to identify the onset of ischemic events before irreversible injury occurs.